These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38837688)

  • 1. HER2-positive mucinous cystadenocarcinoma of the breast coexisting with invasive lobular carcinoma: A case report and review of the literature.
    Guzelis I; Kucukzeybek BB; Uyaroglu MA; Gokova MB; Sezgin G; Kucukzeybek Y
    Diagn Cytopathol; 2024 Sep; 52(9):E208-E214. PubMed ID: 38837688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary mammary mucinous cystadenocarcinoma: cytological and histological findings.
    Sentani K; Tashiro T; Uraoka N; Aosaki Y; Yano S; Takaeko F; Yasui W
    Diagn Cytopathol; 2012 Jul; 40(7):624-8. PubMed ID: 21472867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary mucinous cystadenocarcinoma of the breast with amplification of the HER2 gene confirmed by FISH - case report and review of the literature.
    Kucukzeybek BB; Yigit S; Sari AA; Rezanko T; Durak E; Sadullahoglu C
    Pol J Pathol; 2014 Mar; 65(1):70-3. PubMed ID: 25119013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucinous metaplasia of breast carcinoma with macrocystic transformation resembling ovarian mucinous cystadenocarcinoma in a case of synchronous bilateral infiltrating ductal carcinoma.
    Lee SH; Chaung CR
    Pathol Int; 2008 Sep; 58(9):601-5. PubMed ID: 18801076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucinous cystadenocarcinoma of the breast with amplification of the HER2-gene confirmed by FISH: The first case reported.
    Petersson F; Pang B; Thamboo TP; Putti TC
    Hum Pathol; 2010 Jun; 41(6):910-3. PubMed ID: 20338619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordant HER2 status between primary breast carcinoma and recurrent/metastatic tumors using fluorescence in situ hybridization on cytological samples.
    Arihiro K; Oda M; Ogawa K; Tominaga K; Kaneko Y; Shimizu T; Matsumoto S; Oda M; Kurita Y; Taira Y
    Jpn J Clin Oncol; 2013 Jan; 43(1):55-62. PubMed ID: 23225912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous cystadenocarcinoma of the breast with a basal-like immunophenotype.
    Deng Y; Xue D; Wang X; Xu S; Ao Q; Hu Z; Wang G
    Pathol Int; 2012 Jun; 62(6):429-32. PubMed ID: 22612513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma.
    Chen WY; Chen CS; Chen HC; Hung YJ; Chu JS
    Pathol Int; 2004 Oct; 54(10):781-6. PubMed ID: 15482568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary Mucinous Cystadenocarcinoma of the Breast: Clinicopathological Analysis of a Case and Difficulties Encountered in a Biopsy.
    Özşen M; Tolunay Ş; Gökgöz MŞ; Deligönül A
    Int J Surg Pathol; 2024 Sep; 32(6):1158-1164. PubMed ID: 38073094
    [No Abstract]   [Full Text] [Related]  

  • 10. Invasive pleomorphic lobular carcinoma, negative for ER, PR and Her/2neu--a case report.
    Manucha V; Khilko N; Reilly K; Zhang X
    Int J Clin Exp Pathol; 2011 Jan; 4(2):200-5. PubMed ID: 21326816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed primary mucinous cystadenocarcinoma and invasive ductal carcinoma of the breast: a case report and literature review.
    Zuo C; Xie J
    Transl Cancer Res; 2022 Dec; 11(12):4455-4464. PubMed ID: 36644191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucinous cystadenocarcinoma of the breast: a new entity with broad differentials-a case report.
    Kaur K; Shah A; Gandhi J; Trivedi P
    J Egypt Natl Canc Inst; 2022 Feb; 34(1):9. PubMed ID: 35224708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor (ER), progesterone receptor (PR), and HER2 expression pre- and post- neoadjuvant chemotherapy in primary breast carcinoma: a single institutional experience.
    Kinsella MD; Nassar A; Siddiqui MT; Cohen C
    Int J Clin Exp Pathol; 2012; 5(6):530-6. PubMed ID: 22949935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Classical-type invasive lobular carcinoma with HER2 overexpression: clinical, histologic, and hormone receptor characteristics.
    Yu J; Dabbs DJ; Shuai Y; Niemeier LA; Bhargava R
    Am J Clin Pathol; 2011 Jul; 136(1):88-97. PubMed ID: 21685036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Invasive breast lobular carcinoma with extracellular mucin: a clinicopathological analysis].
    Lyu H; Fu LM; Tu XY; Lu HF; Shui RH; Cheng YF; Li XQ; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):779-783. PubMed ID: 31594042
    [No Abstract]   [Full Text] [Related]  

  • 16. Mammary synchronous mucinous cystadenocarcinoma and columnar cell mucinous carcinoma: a case report.
    Sun M; Su S; Liu Q; Li Q; Wang K
    Int J Clin Exp Pathol; 2020; 13(9):2381-2386. PubMed ID: 33042347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of neoadjuvant chemotherapy on HER2/neu status in invasive breast cancer.
    Li P; Liu T; Wang Y; Shao S; Zhang W; Lv Y; Yi J; Wang Z
    Clin Breast Cancer; 2013 Feb; 13(1):53-60. PubMed ID: 23103368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases.
    Sneige N; Wang J; Baker BA; Krishnamurthy S; Middleton LP
    Mod Pathol; 2002 Oct; 15(10):1044-50. PubMed ID: 12379750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2-positive pure mucinous breast carcinoma: A case report and literature review.
    Zhao X; Yang X; Gao R; Zhai L; Yang L; Yu K
    Medicine (Baltimore); 2020 Aug; 99(33):e20996. PubMed ID: 32871976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association.
    Vegni F; D'Alessandris N; Santoro A; Angelico G; Scaglione G; Carlino A; Arciuolo D; Valente M; Sfregola S; Natale M; Sanchez AM; Masciullo V; Zannoni GF; Mulè A
    J Pers Med; 2023 Jun; 13(6):. PubMed ID: 37373937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.